From 22nd to the 25th August we presented papers simultaneously in Stockholm, Sweden, Milan, Italy and Puerto Rico in the Caribbean.
This happens once in a lifetime of research; for a scientist, its like being on the front page of Times Magazine. The paper is called: GC protein-derived macrophage-activating factor decreases a-N-acetylgalactosaminidase levels in advanced cancer patients. Or to translate: GcMAF decreases nagalase in advanced cancer patients. It follows the excellent improvements in 20 cancer patientsRead More